Literature DB >> 1557415

Independent domain folding of Pseudomonas exotoxin and single-chain immunotoxins: influence of interdomain connections.

U Brinkmann1, J Buchner, I Pastan.   

Abstract

We have studied the refolding of completely unfolded and reduced Pseudomonas exotoxin (PE) and of recombinant single-chain immunotoxins made with monoclonal antibody B3 that are composed of a heavy-chain variable region connected by a flexible linker to the corresponding light-chain variable region (Fv), which is in turn fused to a truncated form of PE. We have found by direct activity assays that different functional domains of these multifunctional proteins fold independently with different kinetics. The ADP-ribosylation domain of PE and of the recombinant immunotoxin fold rapidly, whereas the assembly of the binding and/or translocation domains is regained more slowly. The complete refolding of native PE occurs more rapidly than the refolding of the recombinant immunotoxins. To determine the influence of the connector region between the B3(Fv) moiety and the toxin on the folding process of the recombinant immunotoxin B3(Fv)-PE38KDEL, we have made two different mutations in the peptide that connects the single-chain Fv domain to domain II of PE. These molecules show different folding kinetics, differences in their propensity to aggregate, and different yields of correctly folded molecules. A mutation that decreases aggregation increases the rate of formation and the yield of active immunotoxin molecules.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1557415      PMCID: PMC48806          DOI: 10.1073/pnas.89.7.3075

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   12.779


  32 in total

1.  A kinetic study of the competition between renaturation and aggregation during the refolding of denatured-reduced egg white lysozyme.

Authors:  M E Goldberg; R Rudolph; R Jaenicke
Journal:  Biochemistry       Date:  1991-03-19       Impact factor: 3.162

2.  Global suppression of protein folding defects and inclusion body formation.

Authors:  A Mitraki; B Fane; C Haase-Pettingell; J Sturtevant; J King
Journal:  Science       Date:  1991-07-05       Impact factor: 47.728

3.  Functional analysis of domains II, Ib, and III of Pseudomonas exotoxin.

Authors:  C B Siegall; V K Chaudhary; D J FitzGerald; I Pastan
Journal:  J Biol Chem       Date:  1989-08-25       Impact factor: 5.157

4.  Independent folding regions in aspartokinase-homoserine dehydrogenase.

Authors:  A Dautry-Varsat; J R Garel
Journal:  Biochemistry       Date:  1981-03-03       Impact factor: 3.162

5.  Enzymatically active peptide from the adenosine diphosphate-ribosylating toxin of Pseudomonas aeruginosa.

Authors:  D W Chung; R J Collier
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

6.  Pseudomonas exotoxin contains a specific sequence at the carboxyl terminus that is required for cytotoxicity.

Authors:  V K Chaudhary; Y Jinno; D FitzGerald; I Pastan
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 12.779

7.  Domain II mutants of Pseudomonas exotoxin deficient in translocation.

Authors:  Y Jinno; M Ogata; V K Chaudhary; M C Willingham; S Adhya; D FitzGerald; I Pastan
Journal:  J Biol Chem       Date:  1989-09-25       Impact factor: 5.486

8.  Mutational analysis of domain I of Pseudomonas exotoxin. Mutations in domain I of Pseudomonas exotoxin which reduce cell binding and animal toxicity.

Authors:  Y Jinno; V K Chaudhary; T Kondo; S Adhya; D J FitzGerald; I Pastan
Journal:  J Biol Chem       Date:  1988-09-15       Impact factor: 5.486

9.  Increased cytotoxic activity of Pseudomonas exotoxin and two chimeric toxins ending in KDEL.

Authors:  S Seetharam; V K Chaudhary; D FitzGerald; I Pastan
Journal:  J Biol Chem       Date:  1991-09-15       Impact factor: 5.486

10.  Cloning, nucleotide sequence, and expression in Escherichia coli of the exotoxin A structural gene of Pseudomonas aeruginosa.

Authors:  G L Gray; D H Smith; J S Baldridge; R N Harkins; M L Vasil; E Y Chen; H L Heyneker
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 12.779

View more
  18 in total

Review 1.  Generation of recombinant antibodies.

Authors:  S M Kipriyanov; M Little
Journal:  Mol Biotechnol       Date:  1999-09       Impact factor: 2.695

2.  Bacterially expressed HIV-1 gp120 outer-domain fragment immunogens with improved stability and affinity for CD4-binding site neutralizing antibodies.

Authors:  Ujjwal Rathore; Mansi Purwar; Venkada Subramanian Vignesh; Raksha Das; Aditya Arun Kumar; Sanchari Bhattacharyya; Heather Arendt; Joanne DeStefano; Aaron Wilson; Christopher Parks; Celia C La Branche; David C Montefiori; Raghavan Varadarajan
Journal:  J Biol Chem       Date:  2018-08-09       Impact factor: 5.157

3.  Ternary system of solution additives with arginine and salt for refolding of beta-galactosidase.

Authors:  Akiko Fujimoto; Atsushi Hirano; Kentaro Shiraki
Journal:  Protein J       Date:  2010-04       Impact factor: 2.371

4.  Ionic liquids as refolding additives: N'-alkyl and N'-(omega-hydroxyalkyl) N-methylimidazolium chlorides.

Authors:  Christian Lange; Ganesh Patil; Rainer Rudolph
Journal:  Protein Sci       Date:  2005-10       Impact factor: 6.725

Review 5.  Preparation of recombinant RNase single-chain antibody fusion proteins.

Authors:  Dianne L Newton; Susanna M Rybak
Journal:  Mol Biotechnol       Date:  2002-01       Impact factor: 2.695

6.  L-Arginine increases the solubility of unfolded species of hen egg white lysozyme.

Authors:  Ravi Charan Reddy K; Hauke Lilie; Rainer Rudolph; Christian Lange
Journal:  Protein Sci       Date:  2005-03-01       Impact factor: 6.725

7.  Ribosome-mediated translational pause and protein domain organization.

Authors:  T A Thanaraj; P Argos
Journal:  Protein Sci       Date:  1996-08       Impact factor: 6.725

Review 8.  Antigen recognition and targeted delivery by the single-chain Fv.

Authors:  J S Huston; M S Tai; J McCartney; P Keck; H Oppermann
Journal:  Cell Biophys       Date:  1993 Jan-Jun

9.  Bispecific antibody derivatives with restricted binding functionalities that are activated by proteolytic processing.

Authors:  Silke Metz; Christian Panke; Alexander K Haas; Jürgen Schanzer; Wilma Lau; Rebecca Croasdale; Eike Hoffmann; Britta Schneider; Johannes Auer; Christian Gassner; Birgit Bossenmaier; Pablo Umana; Claudio Sustmann; Ulrich Brinkmann
Journal:  Protein Eng Des Sel       Date:  2012-09-13       Impact factor: 1.650

10.  Novel Therapy for Atherosclerosis Using Recombinant Immunotoxin Against Folate Receptor β-Expressing Macrophages.

Authors:  Yuko Furusho; Masaaki Miyata; Takami Matsuyama; Taku Nagai; Hua Li; Yuichi Akasaki; Narisato Hamada; Takahiro Miyauchi; Yoshiyuki Ikeda; Takahiro Shirasawa; Kanako Ide; Chuwa Tei
Journal:  J Am Heart Assoc       Date:  2012-08-24       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.